CD28 and neoplasm: Finally, in the tumor we observed a significant functional decline of PD1+ T cells lacking both CD28 and the other four IRs (Fig. S8B,C IR-1), suggesting that in the tumor site, in the absence of CD28, additional mechanisms rather than IR expression restrain T-cell functionality.